No Data
Nanjing Pharmaceutical (600713.SH): Heling Pharmaceutical intends to adjust the leasing and renovate part of the factory buildings of Zhongshan Pharmaceutical.
On January 22, Gelonghui reported that Nanjing Pharmaceutical (600713.SH) announced that its holding subsidiary, Nanjing Pharmaceutical Co., Ltd. (referred to as "Nanjing Pharmaceutical"), plans to adjust the lease of part of the factory buildings from Nanjing Zhongshan Pharmaceutical Co., Ltd. (referred to as "Zhongshan Pharmaceutical") located at 21 Hengfa Road, Economic Development Zone, Nanjing, for warehousing and office purposes. After this adjustment, the total leased area for Heling Pharmaceutical Service Co., Ltd. (referred to as "Heling Pharmaceutical") will be 16,871.12 m2 (consistent with the currently leased area, with the specific area based on the real estate property certificate), with the lease term starting from 202.
Nanjing Pharmaceutical (600713.SH): "Nanjiao Convertible Bond" will be listed for Trade starting from January 20.
Nanjing Pharmaceutical (600713.SH) announced that the company's 1.081 billion yuan convertible Bonds will be issued on ...
Is NanJing Pharmaceutical (SHSE:600713) Using Too Much Debt?
nanjing pharmaceutical (600713.SH) has been approved to register 6 billion yuan of ultra-short-term financing bonds.
Nanjing Pharmaceutical(600713.SH) announced that the company received a notice from Bank of China on October 30, 2024...
Nanjing Pharmaceutical: Full text of Nanjing Pharmaceutical\'s 2024 third quarter report
Full text of Nanjing Pharmaceutical\'s 2024 third quarter report
What NanJing Pharmaceutical Company Limited's (SHSE:600713) ROE Can Tell Us